神戸大学附属図書館デジタルアーカイブ
https://hdl.handle.net/20.500.14094/0100479714

このアイテムのアクセス数:60件（2025-07-08 16:54 集計）

閲覧可能ファイル 

ファイル フォーマット サイズ 閲覧回数 説明
0100479714 (fulltext) pdf 375 KB 81

メタデータ

ファイル出力

メタデータID
0100479714
アクセス権
open access
出版タイプ
Version of Record
タイトル
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy
著者
Ishiki, Hiroto ; Kikawa, Yuichiro ; Terada, Mitsumi ; Mizusawa, Junki ; Honda, Michitaka ; Iwatani, Tsuguo ; Mizutani, Tomonori ; Mori, Keita ; Nakamura, Naoki ; Miyaji, Tempei ; Yamaguchi, Takuhiro ; Ando, Masahiko ; Nakamura, Kenichi ; Fukuda, Haruhiko ; Kiyota, Naomi ; PRO/QOL research Committee of Japan Clinical Oncology Group
著者名
Ishiki, Hiroto
著者名
Kikawa, Yuichiro
著者名
Terada, Mitsumi
著者名
Mizusawa, Junki
著者名
Honda, Michitaka
著者名
Iwatani, Tsuguo
著者名
Mizutani, Tomonori
著者名
Mori, Keita
著者名
Nakamura, Naoki
著者名
Miyaji, Tempei
著者名
Yamaguchi, Takuhiro
著者名
Ando, Masahiko
著者名
Nakamura, Kenichi
著者名
Fukuda, Haruhiko
著者ID
A1407
研究者ID
1000040515037
KUID
https://kuid-rm-web.ofc.kobe-u.ac.jp/search/detail?systemId=5fd898ae58a689e3520e17560c007669
著者名
Kiyota, Naomi
清田, 尚臣
キヨタ, ナオミ
所属機関名
医学部附属病院
著者名
PRO/QOL research Committee of Japan Clinical Oncology Group
言語
English (英語)
収録物名
Japanese Journal of Clinical Oncology
巻(号)
53(3)
ページ
195-202
出版者
Oxford University Press (OUP)
刊行日
2023-03
公開日
2023-03-20
抄録
Assessments of patient-reported outcomes and health-related quality of life in cancer clinical trials have been increasingly emphasized recently because patient and public involvement in cancer treatment development has been promoted by regulatory authorities and academic societies. To assess patient experiences during and after cancer treatment, there is interest in implementing patient-reported outcome and health-related quality of life assessments into cancer clinical trials. The Japan Clinical Oncology Group quality of life ad hoc committee previously created a version of the Quality of Life Assessment Policy in 2006. Recently, there has been increasing demand from Japan Clinical Oncology Group researchers to assess patient-reported outcome/health-related quality of life in clinical trials. Although guidelines are available regarding planning and reporting clinical trials that include patient-reported outcome/health-related quality of life as an endpoint, there are still issues regarding the lack of consensus on standardized methods for analysing and interpreting the results. Hence, it was considered necessary to reorganize the Japan Clinical Oncology Group patient-reported outcome/quality of life research committee and to revise the former patient-reported outcome/quality of life research policy to promote patient-reported outcome/health-related quality of life research in future Japan Clinical Oncology Group trials. The purpose of this Japan Clinical Oncology Group patient-reported outcome/quality of life research policy is to define patient-reported outcome/health-related quality of life research and provide guidelines for including patient-reported outcome/health-related quality of life as an endpoint in Japan Clinical Oncology Group trials.
キーワード
JCOG
patient-reported outcome
health-related quality of life
quality of life
endpoint
study design
カテゴリ
医学部附属病院
学術雑誌論文
権利
© The Author(s) 2023. Published by Oxford University Press. All rights reserved.
CC license
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
関連情報
DOI
https://doi.org/10.1093/jjco/hyad007